MedPath

Methimazole

Methimazole Tablets USP

Approved
Approval ID

39159f2f-7291-40cc-b688-14f10104ac10

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 11, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

methimazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-2224
Application NumberANDA040350
Product Classification
M
Marketing Category
C73584
G
Generic Name
methimazole
Product Specifications
Route of AdministrationORAL
Effective DateAugust 11, 2023
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
METHIMAZOLEActive
Quantity: 10 mg in 1 1
Code: 554Z48XN5E
Classification: ACTIB

Drug Labeling Information

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 8/19/2016

CONTRAINDICATIONS

Methimazole is contraindicated in the presence of hypersensitivity to the drug or any of the other product components.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 8/19/2016

HOW SUPPLIED

NDC: 63629-2224-1: 100 Tablets in a BOTTLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methimazole - FDA Drug Approval Details